Mustang Bio, Inc. (MBIO): R&D Expense
$7.56M
Year ended 2024-12-31
-46.7%
3-year compound annual growth
-24.1%
5-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | $7.56M | -81.3% | 2025-03-28, From 2024-01-01 |
| 2023-12-31 | $40.51M | -35.2% | 2025-03-28, From 2023-01-01 |
| 2022-12-31 | $62.48M | +25.3% | 2024-03-11, From 2022-01-01 |
| 2021-12-31 | $49.86M | +33.9% | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | $37.24M | +23.9% | 2022-03-23, From 2020-01-01 |
| 2019-12-31 | $30.04M | +42.4% | 2021-03-24, From 2019-01-01 |
| 2018-12-31 | $21.10M | +165.7% | 2020-03-16, From 2018-01-01 |
| 2017-12-31 | $7.94M | +221.8% | 2019-03-18, From 2017-01-01 |
| 2016-12-31 | $2.47M | n/a | 2018-03-29, From 2016-01-01 |